High Risk Percutaneous Coronary Intervention of Left Main Bifurcation Stenosis in a Peritoneal Dialysis Patient.
Autor: | Bushljetikj O; University Clinic of Cardiology, Clinical Centre 'Mother Theresa', Skopje, N Macedonia., Taleska BZ; University Clinic of Cardiology, Clinical Centre 'Mother Theresa', Skopje, N Macedonia., Zimbakov Z; University Clinic of Cardiology, Clinical Centre 'Mother Theresa', Skopje, N Macedonia., Dezulovic FA; University Clinic of Cardiology, Clinical Centre 'Mother Theresa', Skopje, N Macedonia., Rambabova-Bushljetik I; University Clinic of Nephrology, Clinical Centre 'Mother Theresa', Skopje, N Macedonia., Spasovski G; University Clinic of Nephrology, Clinical Centre 'Mother Theresa', Skopje, N Macedonia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) [Pril (Makedon Akad Nauk Umet Odd Med Nauki)] 2021 Oct 26; Vol. 42 (2), pp. 71-78. Date of Electronic Publication: 2021 Oct 26. |
DOI: | 10.2478/prilozi-2021-0023 |
Abstrakt: | Complex coronary artery disease is the leading cause of death in patients with end-stage renal disease. We report a case of a patient on peritoneal dialysis, preloaded with Prasugrel and acetylsalicylic acid as а potent dual antiplatelet therapy (DAPT). The patient underwent a high-risk percutaneous coronary intervention (PCI) due to bifurcation stenosis of the left main stem branch. A "double kiss crush" bifurcation stenting technique was performed. This case provides additional data about the treatment of this group of patients, a group that is often excluded from randomized control trials, but is frequently encountered in cardiovascular practice. Furthermore, it helps to advance PCI treatment along with exploring the safety of potent DAPT in a group that is susceptible to both ischemia and bleeding, thus presenting a great challenge in the decision for treatment. (© 2021 Oliver Bushljetikj et al., published by Sciendo.) |
Databáze: | MEDLINE |
Externí odkaz: |